>Couldn't this constitute another approved generic in the context of lowering MNTA’s royalty rate? Or would the sole approved generic designation apply to each of the specific product formulations?<
The latter. Technically, the Sandoz-MNTA Lovenox collaboration consists of two products: the vial and the syringe. Each of these has its own ANDA.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.